Home > HP > Meetings and Conferences

Return to PJ Online Home Page
Vol 8 No 6 p152
June 2001

Meetings

Self-regulation in hospital pharmacy

The Royal Pharmaceutical Society’s Hospital Pharmacists Group recently held a conference on the application of clinical governance requirements, focusing on the need to ensure the competence of pharmacy staff

Introduction
A case for specialisms in pharmacy



Introduction

Jeanette Howe, deputy chief pharmacist at the Department of Health, said that the present situation where there was no widely applicable system for recognising postregistration achievement among pharmacists was unlikely to persist. This was because the acquisition of prescribing rights by certain pharmacists would mean that they had to be clearly identified.

Ann Lewis, Secretary and Registrar of the Royal Pharmaceutical Society, pointed out that self-regulation in pharmacy was more challenging than it was for nurses. This was because over 90 per cent of nurses worked for the National Health Service while only a relatively small proportion of pharmacists worked in the managed environment of the NHS.

David Miller, chief pharmacist at South Tyneside Healthcare NHS Trust and representative of the Guild of Healthcare Pharmacists, identified the need for future professional leaders. He lamented the fact that currently there were no core competencies for chief pharmacists. Mr Miller also said that hospital pharmacy practice should be based on sound research.

Back to Top


A case for specialisms in pharmacy

The National Health Service is now an uncomfortable environment for health professionals to work. This was the view expressed by Clive Jackson, director of the National Prescribing Centre.

Mr Jackson said that the NHS has become uncomfortable due to increased workload in the face of limited professional resources, new and complex health care technologies and interventions, increased media interest in problems with health care, an increasingly litigious society, poor performance from a minority of professionals, and better informed (and thus more demanding) patients.

In response to this uncomfortable environment, the Government has, among other things, issued national guidance (in the form of National Institute for Clinical Excellence guidelines and National Service Frameworks), developed quality initiatives (clinical governance) and introduced legal instruments (Health Act 1999, Health and Social Care Act 2001). Professional bodies have also had to make changes, such as improving disciplinary procedures and attempting to introduce re-validation at regular intervals.

For pharmacists, the issues that are likely to be of concern are:

  • Definition of competencies. Questions that need to be answered include: What are core competencies? Would the achievement of core competencies allow a pharmacist to practise in specialist areas? Could those with specialist competencies undertake tasks requiring the core competencies? How would definition of competencies affect professional flexibility, that is, the ability to move from one area of practice to another?
  • Validation and re-validation processes. These are necessary in order to assure the Government and members of the public of professional competence
  • Maintaining competencies. A distinction has to be made between continuing education (CE) and continuing professional development (CPD). Monitoring CE and CPD is essential but would require some time commitment

In addressing the issue of competence, Mr Jackson said that it would be necessary to consider who would produce the competencies and how they would be produced. One option for the pharmacy profession is to consider setting up a faculty for each specialty. Mr Jackson said that specialist pharmacy faculties, similar to the specialist colleges that exist in the medical profession, would be highly influential with the Government. He said that, in the medical profession, the Royal colleges provide a professional framework for the various specialties. A collegiate system also provides recognition for members both within and outside the profession, as the qualifications would be indicative of the attainment of a certain level of competence (such as membership of the Royal College of General Practitioners, or MRCGP, for GPs).

The establishment of colleges would provide an alternative to a situation where the Society has to produce competencies for the “core” competencies, as well as specialist competencies. Mr Jackson said that, in practical terms, it would be difficult for the Society to accomplish this task as it would require extra manpower and other resources. In addition, undertaking the task could distract the Society from other issues.

Mr Jackson recognised that there are not as many pharmacists as there are medical practitioners. Consequently, the number of pharmacists in each specialty would be quite few and the large number of specialties could lead to fragmentation in the profession. He therefore proposed that a number of faculties could be established under an umbrella organisation, such as the recently formed faculty of prescribing and medicines management under the College of Pharmacy Practice. This would avoid duplication of efforts and administration.

Other benefits of the faculty system are that the faculties could provide opportunities for professional networking and peer support, accredit relevant training for members, disseminate good practice and aid in the re-validation exercise.

Answering a question from the floor, Mr Jackson said that the extent to which various aspects of pharmacy practice could be specialised is open to debate but that, for logistical reasons, a faculty would need to have at least 200 members. There is also the effect of specialisation on registration status. For example, would specialisation mean that specialists could only be conditionally registered. Mr Jackson said that issues such as this had to be addressed.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal